RSV vax market estimated to surpass $9 billion by 2029: Report
New York, July 24 (SocialNews.XYZ) The respiratory syncytial virus (RSV) vaccine market is likely to surpass $9 billion by 2029, a growth of over $8 billion from 2023, according to a report on Monday. The…